ArticleBMC neurology2025
Hypokalemia in chronic migraine with medication overuse headache: a retrospective cross-sectional study.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPotassium may be involved in the pathogenesis of migraine. Patients with chronic migraine and medication-overuse headache (CM-MOH) appear to be at a high risk for hypokalemia.
methodsA retrospective cross-sectional study enrolled 139 consecutive patients with CM-MOH and 139 age- and sex-matched patients with healthy controls from our center. The demographic and clinical characteristics of the patients were recorded upon admission. The following morning, blood tests for potassium and magnesium concentrations were performed.
resultsThe mean age of patients in the two groups was 48.60 ± 11.81 (CM-MOH) vs. 48.69 ± 11.99 (control). Migraineurs had a significantly lower serum potassium level (3.76 ± 0.35 mmol/L vs. 4.03 ± 0.30 mmol/L p < 0.001) and a higher prevalence of hypokalemia (21.6% versus 2.2% p < 0.001) compared to controls. A positive association between potassium and magnesium levels was observed in patients with CM-MOH (r = 0.25, p = 0.004). A slightly higher level of Mg (0.90 ± 0.06mmol/L versus 0.89 ± 0.05mmol/L, p = 0.012) was detected in the CM-MOH group compared to controls. According to logistic regression models, BMI was associated with the presence of hypokalemia in patients with CM-MOH.
conclusionThe incidence of hypokalemia in the control group was similar to that in the general population. An increased incidence of hypokalemia and lower serum potassium levels were observed in patients with CM-MOH. It is important to monitor the serum potassium levels in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.